Cohance Lifesciences Schedules Investor Interactions with JP Morgan
Cohance Lifesciences Ltd 路 Intimation 路 17 Sept 2026, 6:30 pm
Cohance Lifesciences Schedules Investor Interactions with JP Morgan Cohance Lifesciences Limited (formerly Suven Pharmaceuticals Limited) announced its management will participate in upcoming investor conferences hosted by JP Morgan. The schedule includes the JP Morgan India Conference in Mumbai on 22nd Sep'26 for group and one-on-one meetings, followed by the JP Morgan Roadshow in Hyderabad on 24th Sep'26 for group interactions. The company confirmed that no unpublished price-sensitive information will be shared during these interactions.
Original exchange filing (PDF)
More announcements from Cohance Lifesciences Ltd
- The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasti Property and Equity Holdings .... 路 12 Nov 2026
- The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasub Property Holdings LLP & Others 路 12 Nov 2026
- Investors Meet 路 11 Nov 2026
- Transcript of Con call 路 11 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasub Property Holdings LLP & Others 路 11 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasti Property and Equity Holdings Pvt Ltd & Others 路 11 Nov 2026
- Investor Presentation 路 07 Nov 2026
- Update on USFDA inspection at Pashamylaram Manufacturing facility. 路 07 Nov 2026
